Fludarabine Pharmacokinetic Model-Based Dosing Minimizes the Risk of Graft Rejection in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.

Transplantation and cellular therapy
2025
https://researcherprofiles.org/profile/711784222
41365398
Dvorak CC, Waters E, Temple WC, Salinas GC, Chu J, Winestone LE, Higham CS, Kharbanda S, Shimano KA, Avagyan S, Pauerstein P, Huang JN, Brooks JT, Long-Boyle JR